<DOC>
	<DOCNO>NCT01745679</DOCNO>
	<brief_summary>The aim study describe concentration Ceftriaxone steady state , patient treat meningitis , determine pharmacokinetic parameter high dose population . Additionally , aim detect adverse effect , especially neurological trouble relate Ceftriaxone toxicity .</brief_summary>
	<brief_title>Pharmacological Study High Doses Ceftriaxone Meningitidis</brief_title>
	<detailed_description>Day 0 : onset treatment Ceftriaxone , follow usual therapeutic process ( French Guideline ) From Day 0 Day 4 : inclusion , clinical biological data collection , electroencephalogram baseline . Two sample ceftriaxone concentration monitoring : - Trough concentration ceftriaxone steady state - A random sample ( population PK ) At end ceftriaxone treatment : assessment tolerance efficacy treatment .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<criteria>Hospitalized adult patient , age equal 18 Patients Community surgical acquire neurological infection , meningitis others Prescription ceftriaxone &gt; 75mg/kg/d &gt; 4g/d Subjects affiliate French health insurance ( social security ) Informed consent form sign Patient guardianship</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Ceftriaxone</keyword>
	<keyword>Adverse drug effect</keyword>
	<keyword>Therapeutic monitoring</keyword>
	<keyword>Meningitis</keyword>
</DOC>